EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditing Electronic data capture in clinical trials (EDC) – The auditor’s view  Where do auditors see.

Slides:



Advertisements
Similar presentations
How to Validate a Vendor Purchased Application
Advertisements

Essential Documentation GCP Training Seminar 12th October 2011
Tips to a Successful Monitoring Visit
The New GMP Annex 11 and Chapter 4 Deadline for coming into operation: 30 June 2011.
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download,
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
GMP Document and Record Retention
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Supplementary Training Modules on Good Manufacturing Practice
Using EDC-Rave to Conduct Clinical Trials at Genentech
Laboratory Information Management Systems (LIMS) Lindy A. Brigham Div of Plant Pathology and Microbiology Department of Plant Sciences PLS 595D Regulatory.
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
An introduction to CDISC and CDASH Bring on the Standards! Emmanuelle Denis M.Sc., MICR Global Health Clinical Trials Research Programme.
5.2 Personnel Use competent staff Supervise as necessary
11/2/991 CDER’s 21 CFR Part 11 Implementation Study Greg Brolund Associate Director, Office of Information Technology, CDER/FDA.
Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum 21 CFR Part 11 Considerations November 14, 2002.
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
Instructions and forms
QC | Slide 1 of 16 June 2006 Good Practices for Quality Control Laboratories P art 4: Inspecting the laboratory Supplementary Training Modules on Good.
Draft Guidance for Industry Electronic Source Documentation in Clinical Investigations FDA Guidance Overview.
Computer Systems & Software
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency1 GMP Workshop Kuala Lumpur.
Regulatory Overview.
MethodGXP The Solution for the Confusion.
Kyle McDuffie, Vice President Beckman User Meeting 2001 Delaware. Orlando. Holland. UK Instrument Integration and Regulatory Compliance.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
FDA Docket No. 2004N-0133 Themes for Renewal of 21 CFR Part 11 Rule & Guidance by Dr. Teri Stokes, GXP International
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
MODULE B: Case Report Forms Jane Fendl & Denise Thwing April 7, Version: Final 07-Apr-2010.
1. Re-Use of Clinical Care and of Clinical Trial Data A Contract Research Organisation (CRO) point of view EuroRec Conference 2009 Sarajevo Selina Sibbald.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
Part 11, Electronic Records; Electronic Signatures
Using EDC-Rave to Conduct Clinical Trials at Genentech Susanne Prokscha Principal CDM PTM Process Analyst February 2012.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Electronic Records and Signatures: Warning Letters and Observations including proposed solutions.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
FDA Part 11 Public Meeting Washington, DC June 11, 2004 Paul D’Eramo Executive Director Worldwide Policy & Compliance Management Quality & Compliance Services.
The world leader in serving science OMNIC DS & Thermo Security Administration 21 CFR Part 11 Tools for FT-IR and Raman Spectroscopy.
SEMINAR ON, PRESENTED BY, POONAM Y AGHARA M – PHARM DEPT. OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY L. M. COLLEGE OF PHARMACY AHMEDABAD.
Laboratory equipment Dr. W. Huisman Cairo, November 21th 2012.
Scientific data storage: How are computers involved in the following?
WHO - PSM Basic Principles of GMP Documentation - Part 1 Workshop on GMP and Quality Assurance of HIV products Shanghai, China 28 Feb - 4 March 2005 Maija.
GCP (GOOD CLINICAL PRACTISE)
Responsibilities of Sponsor, Investigator and Monitor
21 CFR PART 11.
FDA 21 CFR Part 11 Compliance
Overview eSignature Features: Field Type vs Record Locking Regulations
DOCUMENT AND DATA CONTROL
EDC Management Sheet in Japan
Международные требования к использованию электронных систем в клинических исследованиях Timur Galimov, CTO.
World Health Organization
Responsibilities of Sponsor, Investigator and Monitor
Investigator of Record – Definition
Worldwide Development Quality Assurance
CLINICAL DATA MANAGEMENT
Basics of Building and Understanding Data Collection Forms
Computer System Validation
בקרה תוך שימוש ב 21CFR Part 11 / אילן שעיה סמארט לוג'יק
Investigator of Record – Definition
FDA 21 CFR Part 11 Overview June 10, 2006.
Investigator of Record – Definition
Computer System Validation
Radiopharmaceutical Production
Presentation transcript:

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditing Electronic data capture in clinical trials (EDC) – The auditor’s view  Where do auditors see such systems?  Regulatory basic documents  Key requirements  Validation  Auditfindings -Computer-Systems in hospital and outpatient clinic setting -Findings due to technical issues -Implementation of a study protocol into an EDC-System -Related mistakes following cumbersome data documentation  Conclusions -Preparation before use of an EDC-System -The future

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK  Patient and volunteer data are increasingly often entered and stored in EDC-systems. Outpatient clinic computers or hospital computer systems will more and more substitute the classic paper patient file.  Commercially developed systems as well as self-programmed systems e.g. support of clinical investigations in Clamp-Studies in Diabetes-Research or psychometric tests.  During CRO-Audits (e.g. in Clinical Pharmacology units) we see EDC-Systems, which support the study conduct and are used for documentation of data.  During investigational site audits special systems for data entry (provided by the pharmaceutical company) are evaluated. Where do auditors see EDC Systems?

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK  Electronic Records, Electronic Signatures – 21 CFR part 11 – March 1997  Annex11 to GMP guide: Supplementary guidelines for computerized systems – 1992  The application of the principles of GLP to computerized systems – 1995  Guidance for Industry, Computerized Systems used in Clinical Trials – April  FDA Compliance Programm Guidance Manual – Compliance Programm for Sponsors, Contract Research Organisations and Monitors – October 30, 1998 updated February 21, 2001 and Compliance Program for Clinical Investigators – September 2, 1998  International Conference on Harmonisation, Good Clinical Practice: Consolidated Guideline – January 1997  Additional local laws e.g. for Germany: Drug law, data protection law, signature law.  GAMP (Good Automated Manufacturing Practice) Regulatory basic documents

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Valid for: 21 CFR Part 210,211 GMP 21 CFR Part 58 GLP 21 CFR Part 50,54, 312,314 GCP 21 CFR Part 11

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK  Applies to all electronic records used to meet GxP requirements, including systems for: - Batch records, SOPs, test methods, specs, and policies - Chromatography data systems - LIMS systems - Automated document management systems - Inventory records - Calibration and preventive maintenance records - Validation protocols and reports - Training records - Customer complaint files - Adverse event reporting systems Valid for:

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK 21 CFR Part 11 – Subpart A, Section 11.3(6) -Definition: „Electronic record means any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system.“ What is an “electric record”?

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK  „... Electronic records must be archived in electronic form. The electronic records must be protected to enable their accurate and ready retrieval throughout the relevant retention period...“  Keep accurate transcriptions or complete copies of data and „metadata“ on durable media  Keep links between e-signature and electronic document  Tighter controls may be required for „open“ systems (encryption & digital sigs) Archival Requirements

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Key requirements  Validation- Adequate validation including documentation  User Support- Availability of SOPs - Adequate training for the user - Support “Hotline” of the provider  Access administration- Only authorized persons receive data entry and access rights - Identifyable users (User ID, Password) - Documentation of system use times  Data Security- Protection against data manipulation, back-ups and contingency plans - “Human Readability” of data after system change  Audit Trail- Recording of all datachanges in an audit trail  Data validation /- GAMP validation standard? Systemvalidation- Definition of entry checks; plausibility checks?

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Validation – general documents  Corporate validation policy  Change control procedure  Issues management procedure  Document management procedure  Validation guidelines  Master validation plan  Validation maintenance procedure  Standard Oerationg Procedures (SOPs) for users  End user training manual

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Validation – concrete steps  Definition of functional requirements  System specification  Software specifications  Installation qualification (IQ)  Operational qualification (OQ)  Performance qualification (PQ)  Results and reports for IQ, OQ, PQ  Final validation report  User acceptance test and release for use

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditfindings (1) Computer /EDC-Systems in hospital and outpatient clinic setting  Computerized patient charts in hospitals and outpatient clninics currently do not fulfill the regulatory requirements of EDC-systems as they are designed for another purpose (e.g. for health insurance needs). -missing audittrail -unlimited acccess for the whole personel of a hospital / outpatient clinic -deficient datasecurity -missing SOPs and documented training -inadequate or missing validation of programs  Data entry in the computer requires more time compared to handwritten CRF entries. Adaptability of an EDC-System to the routine workflow is limited. Data entry errors may increase.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditfindings (2a) Findings due to technical issues  Patient data and measured values can be entered repeatedly. Previous data are altered or deleted without recording in an audittrail.  On paper printouts the “print date” in stead of the measurement date is printed.  Saving of entered data was not automated leading to loss of data.  Data are not adequately secured on the harddisc, e.g. no re-write protection. Manipulation possible.  During transfer of laboratory data, units are changed without previous co-ordination, warning or notification.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditfindings (2b) Findings due to technical issues  While the monitor was logged in to the system the investigator couldn’t work.  Data transfer from the investigator to the host of the system wasn’t possible several days. Potential for data loss.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditfindings (3) Implementation of study protocol in to the EDC-System  The parallel work on related CRF-pages was not possible. User unfriendly navigation in the e-CRF leads potentially to higher error rate (motivation decreases).  Data were deleted by the system during review process.  Computer accepts no calibrated data e.g. from lab devices.  Pre-defined data checks are not carried out.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Auditfindings (4) Related mistakes following cumbersome data documentation  Data were initially documented on paperprint outs. Paper hospital chart, paper-CRF and e-CRF are available. This leads to inconsistencies, more work for the physician, increase of error rate, increase in paper load.  Manual entry of data by an investigator e.g. from patient diaries leads to increased error rates (the investigator is not a trained datatypist). Investigators state that they only need 1/3 of time for handwritten documentation compared to electronic entry.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Conclusions (1a) Preparation before use of an EDC-System  Before using EDC-systems it has to be ensured that regulatory requirements are met. Quality Assurance can add value to this process.  An upfront detailed definition of requirements and their continuous follow up may avoid complications.  The procedure of recording of source data in e-trials has to be defined for each center up front.  The investigator should be freed from manual entry of lab data or Qol. questionnaires. Professional double data entry minimizes errors.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Conclusions (1b) Preparation before use of an EDC-System  Currently investigators see themselves often as datatypists for the sponsor company.  The study team and the team at the investigator site need intensive training and supervision before implementation of such a system.  The preparedness to work with such a system also at the investigational site as well as the training to use it is vital and decides about succes or failure. An effective hotline and support is vital.

EDC_Electronic data capture, Dr. J.-H. Schmidt/RK Conclusions (2) The Future  EDC-Systems should be able in future to import labdata from various sources.  The use of EDC systems is currently impeded by problems with portability. Therefor data are not entered directly but have to be documented on paper first. Wireless lans may solve this in the future.  EDC-Systems will be used more and more frequently in the future. The resources and expenditure needed, especially at the beginning of a trial are tremendous. An enhanced possibility of adaption of such systems to routine clinical practice is needed.